Merck/MSD corporate VC investing in digital health and data science that optimises pharmaceutical and hospital operations, improves patient outcomes, and drives healthcare system efficiency.
Merck GHI Fund backs hospital operations technology that directly impacts patient outcomes — MOVO-X is exactly that. Our AI triage and queue management platform reduces patient wait times, increases clinical throughput, and generates the structured patient data that pharma companies need for real-world evidence. A strategic investment from Merck GHI unlocks pharma partnerships, hospital procurement relationships, and the regulatory credibility that accelerates MOVO-X's global expansion.
Malaysia's largest private hospital group. Bursa-listed. JCorp majority. 30+ hospitals across 13 Malaysian states. Advanced discussions underway — significant potential for enterprise-wide AI triage, queue management, and kiosk check-in deployment.
Multi-tenant SaaS active across Quebec and Ontario clinic networks. PIPEDA + Law 25 compliant. Interac and Stripe payments. Architecture validated across clinic groups.
Full PDPA (SG), HBRA, and NEHR integration architecture complete. PayNow + NETS + Stripe. English and Mandarin. Strong pipeline potential with Singapore hospital groups.
We'd love to walk you through our product, architecture, and pipeline. If healthcare AI in ASEAN fits your mandate, we should have a conversation.